Storx Technologies is a cutting-edge startup with a mission to revolutionize fetal health monitoring during childbirth, aiming to reduce unnecessary Cesarean section deliveries. As a University of California medical device spinoff, Storx has developed breakthrough technology through years of collaborative basic engineering-medical research. This innovation holds the potential to benefit Payers by reducing the rate of C-Section deliveries, thus lowering costs, as well as Providers by mitigating malpractice liability, and ultimately enhance Patients' maternal and fetal health outcomes.
Founded in 2019, Storx Technologies operates in the Health Care industry, with its headquarters located in the United States. The latest investment of $225.00K was a grant received on 01 May 2020 from the National Science Foundation.
Overall, Storx Technologies presents an innovative solution with substantial potential to make a meaningful impact in maternal and fetal health, backed by solid research and supported by notable investment from esteemed entities like the National Science Foundation.